AZTA
Azenta, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$34.84
+2.20%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$34.55
From 52W high−18.46%
Volume712319.00
Market cap$1.53B
P/E (TTM)—
P/S (TTM)2.5x
Div yield—
Key dataOct 19, 2026
Open
$34.55
From 52W high
−18.46%
Volume
712319.00
Market cap
$1.53B
ValuationView details →
P/E (Fwd)
65.3x
EV/EBITDA
−13.0x
P/E (TTM)
—
RSI (14)
49.1
MomentumView details →
1D Return
+2.20%
YTD Return
+5.74%
SummaryUpdated Jun 1, 2026
Azenta, Inc. (NASDAQ:AZTA) is a life sciences company that provides sample exploration and management solutions to pharmaceutical companies, biotechnology firms, biorepositories, and research institutes globally. Founded in 1978 as Brooks Automation, the company underwent a significant transformation in 2021 when it changed its name to Azenta and refocused entirely on the life sciences sector after divesting its semiconductor automation business. Headquartered in Chelmsford, Massachusetts, Azenta operates through two primary segments: Life Sciences Products and Life Sciences Services, serving customers across North America, Europe, China, and the Asia Pacific region.
Similar companies
Latest newsMore news →
Azenta, Inc. granted Senior Vice President, General Counsel and Corporate Secretary Ephraim Starr a retention award of restricted stock units valued at $500,000 effective September 14, 2026.32d agoAzenta, Inc. granted Executive Vice President and Chief Financial Officer Lawrence Lin a retention award of restricted stock units valued at $1,000,000 effective September 14, 2026.32d agoAzenta, Inc. appointed Robyn C. Davis to its Nominating and Governance Committee effective September 14, 2026.32d ago